Rankings
▼
Calendar
MESO Q3 2023 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-3.6% YoY
Gross Profit
-$11M
-586.5% margin
Operating Income
-$14M
-745.9% margin
Net Income
-$19M
-959.3% margin
EPS (Diluted)
$-0.25
QoQ Revenue Growth
-2.1%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$791,000
Balance Sheet
Total Assets
$650M
Total Liabilities
$168M
Stockholders' Equity
$482M
Cash & Equivalents
$48M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
-3.6%
Gross Profit
-$11M
-$12M
+3.9%
Operating Income
-$14M
-$19M
+25.2%
Net Income
-$19M
-$21M
+12.7%
← FY 2023
All Quarters
Q4 2023 →